-
-
- R&D Unit
- Industrial Vaccine Production Unit
- Vaccine and Immunization Training Unit
- Vaccine Epidemiology Unit
- Preclinical and Clinical Research and Project Coordination Unit
- Epidemiology of Pandemic-Risk Infectious Agents Unit
- Bioterrorism Unit
- Laboratory Animal Production/Testing and Preclinical Research Unit
- Tissue Culture Collection, Viral and Bacterial Culture Banking Unit
- Quality Control Laboratory Unit
- Training, Administrative, and Financial Services Unit
-
-
-
- Announcements
- Key Dates
- FAQ
- Contact
Turkovac Clinical Trials Primary Phase III
A Randomized, Multi-Centre, Observer-Blind Phase III Clinical Study Evaluating the Efficacy, Immunogenicity, and Safety of Two Doses of Inactivated COVID-19 Vaccine (TURKOVAC) Against Two Doses of CoronaVac (Sinovac) Vaccine in Healthy Volunteers
Turkovac Clinical Trials Booster Phase II
Double-Blind, Randomized, Controlled, Multi-Centre Phase 2 Clinical Study to Determine the Safety, Efficacy, and Immunogenicity of Booster Vaccination Against SARS-CoV-2 (Hybrid COV-Booster TR)
Turkovac Clinical Trials Booster Phase III
Open-Label, Multi-Centre, Phase 3 Clinical Study to Determine the Efficacy, Safety, and Immunogenicity of Booster Vaccination Against SARS-CoV-2
Turkovac Clinical Trials Booster Phase IIB
A Single-Arm, Open-Label, Multi-Centre, Phase 2b Clinical Study to Determine the Efficacy, Safety, and Immunogenicity of Booster Vaccination (TURKOVAC) Against SARS-CoV-2